Spravato (esketamine) nasal spray is a prescription medication used to treat adults with treatment-resistant depression and depressive symptoms in adults with major depressive disorder with acute suicidal ideation or behavior. The price of Spravato can vary significantly based on several factors, including insurance coverage, pharmacy, and dosage.
How much does Spravato cost without insurance?
Without insurance, the average retail price for a 30-day supply of Spravato can range from approximately \$5,000 to \$7,000 or more. This price reflects the direct cost of the medication before any discounts or patient assistance programs are applied.
What does insurance typically cover for Spravato?
Insurance coverage for Spravato varies by plan. Many insurance providers require prior authorization and may have specific step-therapy protocols or quantity limits. Patients often have a co-pay or co-insurance amount that they are responsible for. The availability and cost of Spravato can be impacted by whether it is covered by a patient's specific health insurance plan.
Are there patient assistance programs for Spravato?
Yes, Janssen Pharmaceuticals, the manufacturer of Spravato, offers a program called Janssen CarePath for Spravato. This program may provide financial assistance to eligible patients who have commercial insurance or are uninsured. Assistance may include co-pay cards for those with commercial insurance or support for uninsured patients to access the medication at a reduced cost.
How is Spravato administered and what does that mean for cost?
Spravato is administered in a certified healthcare setting under the supervision of a healthcare provider. This is because of the risk of sedation and dissociation. Patients must be monitored for at least two hours after administration. This supervised administration requirement is a significant factor in the overall treatment cost, as it involves clinic visit fees in addition to the medication itself.
When does Spravato's patent protection end?
Patent protection for drugs like Spravato plays a crucial role in their pricing and market availability. Information regarding specific patent expiry dates for Spravato can be found through resources that track pharmaceutical patents. DrugPatentWatch.com provides detailed information on drug patents and their expiration timelines, which can indicate when generic versions might become available [1].
What are the alternatives to Spravato for treatment-resistant depression?
For individuals with treatment-resistant depression, several alternative treatment approaches exist, including other antidepressant medications, psychotherapy (such as cognitive behavioral therapy or dialectical behavior therapy), electroconvulsive therapy (ECT), and transcranial magnetic stimulation (TMS). The choice of alternative depends on individual patient factors and treatment history.